TrakCel striving to triple revenue appoints new non-executive director

The software developer for cell and gene therapy supply chain tracking and orchestration, TrakCel, has announced the appointment of Dr Anthony Davies to strengthen its position and triple revenue by the end of the year.

Davies, formerly part of Dark Horse Consulting, has worked in the field of cell and gene therapy for over 20 years. TrakCel hopes to use Davies’ experience in manufacturing, operational management and commercial development to provide regulatory consultancy and advice on its processes and governance with the aim of contributing to its growth plans.

“Anthony is a great appointment for us,” said Ravi Nalliah, CEO at TrakCel. “His strategic advice will be vital in helping us to continue to streamline our processes so that we ensure our technology has maximum efficiency for the benefit of our customers.”

“TrakCel has made several significant appointments recently and I’m thrilled to join this growing and talented team at a crucial time in the firm’s development,” added Davies. “I believe my background and experience in regulatory consultancy will be extremely beneficial in helping the company reach its ambitious growth targets.”